Cynata Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Net Income	-9.39	-9.74	-14.28	-5.45	-7.69	Upgrade
Depreciation & Amortization	-	-	-	0.28	0.28	Upgrade
Other Amortization	0.28	0.28	0.28	-	-	Upgrade
Stock-Based Compensation	0.26	0.23	0.33	1.03	1.54	Upgrade
Other Operating Activities	0	0	0.07	-0.17	-0.05	Upgrade
Change in Accounts Receivable	0.03	0.36	-0.36	0.02	-0.16	Upgrade
Change in Accounts Payable	0.04	-1.12	-0.26	0.95	0.74	Upgrade
Change in Other Net Operating Assets	0.05	0.03	-0.07	0.03	0.17	Upgrade
Operating Cash Flow	-8.72	-9.96	-14.28	-3.3	-5.16	Upgrade
Sale (Purchase) of Intangibles	-0.05	-	-	-	-	Upgrade
Investing Cash Flow	-0.05	-	-	-	-	Upgrade
Issuance of Common Stock	8.14	-	7.04	-	18.31	Upgrade
Other Financing Activities	-0.52	-	-0.32	0.21	-0.11	Upgrade
Financing Cash Flow	7.61	-	6.72	0.21	18.2	Upgrade
Foreign Exchange Rate Adjustments	-0	-0	-0.07	0.17	0.03	Upgrade
Net Cash Flow	-1.16	-9.96	-7.63	-2.92	13.07	Upgrade
Cash Income Tax Paid	-1.89	-2.32	-1.65	-0.83	-1.39	Upgrade
Levered Free Cash Flow	-5.44	-6.61	-9.38	-1.27	-2.34	Upgrade
Unlevered Free Cash Flow	-5.44	-6.61	-9.38	-1.27	-2.34	Upgrade
Change in Working Capital	0.13	-0.73	-0.68	1.01	0.76	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.